Stephen R Broderick

2PUBLICATIONS
32CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Nov 15, 2024
Divergent Clinical and Immunologic Outcomes Based on STK11 Co-mutation Status in Resectable KRAS-Mutant Lung Cancers Following Neoadjuvant Immune Checkpoint Blockade.

Samuel Rosner, Sydney Connor, Khaled Sanber

|Feb 16, 2023
Five-Year Clinical Outcomes after Neoadjuvant Nivolumab in Resectable Non-Small Cell Lung Cancer.

Samuel Rosner, Joshua E Reuss, Marianna Zahurak

Pageof 1